Presenting life with cystic fibrosis: A Q-methodological approach to developing balanced, experience-based prenatal screening information

Health Expectations

Volumn 18, Issue 5, 2015, Pages 1349-1362

  Wright, Katherine F ^a   Bryant, Louise D ^b   Morley, Stephen ^b   Hewison, Jenny ^b   Duff, Alistair J A ^c   Peckham, Daniel ^c  

^a BRADFORD TEACHING HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^b UNIVERSITY OF LEEDS   (United Kingdom)

^c LEEDS TEACHING HOSPITALS NHS TRUST   (United Kingdom)

Author keywords

Cystic fibrosis; Prenatal screening information; Q methodology

Indexed keywords

ADAPTIVE BEHAVIOR; CYSTIC FIBROSIS; FEMALE; GENETIC SCREENING; GENETICS; GREAT BRITAIN; HEALTH CARE POLICY; HEALTH EDUCATION; HUMAN; INTERPERSONAL COMMUNICATION; INTERVIEW; PERSONALITY TEST; PREGNANCY; PRENATAL DIAGNOSIS; PROCEDURES;

ADAPTATION, PSYCHOLOGICAL; CYSTIC FIBROSIS; DISCLOSURE; FEMALE; GENETIC TESTING; GREAT BRITAIN; HEALTH EDUCATION; HEALTH POLICY; HUMANS; INTERVIEWS AS TOPIC; PREGNANCY; PRENATAL DIAGNOSIS; Q-SORT;

EID: 84942295467     PISSN: 13696513     EISSN: 13697625     Source Type: Journal    
DOI: 10.1111/hex.12113     Document Type: Article

References (40)

1. Raffle AE. Information about screening: is it to achieve high uptake or to ensure informed choice? Health Expectations, 2001; 4: 92-98.
2. NICE. NICE Clinical Guideline 62. Antenatal Care: Routine Care for the Healthy Pregnant Woman. London: NHS, 2008.
3. Entwistle V. Considering 'balance' in information. Health Expectations, 2007; 10: 307-308.
4. Walters S, Mehta A. Epidemiology of cystic fibrosis. In: Hodson M, Geddes D, Bush A (eds) Cystic Fibrosis, 3rd edn. London: Hodder Arnold, 2007: 433-441.
5. Cystic Fibrosis Trust. UK CF Registry Annual Data Report 2009. Cystic Fibrosis Trust: Bromley, 2011.
6. Dodge J, Lewis P, Stanton M, Wilsher J. Cystic fibrosis mortality and survival in the UK: 1947-2003. European Respiratory Journal, 2007; 29: 522.
7. Anderson P. Emerging therapies in cystic fibrosis. Therapeutic Advances in Respiratory Disease, 2010; 4: 177-185.
8. Grosse SD, Rosenfeld M, Devine OJ, Lai HJ, Farrell PM. Potential impact of newborn screening for cystic fibrosis on child survival: a systematic review and analysis. The Journal of Pediatrics, 2006; 149: 362-366.
9. Conese M, Ascenzioni F, Boyd AC et al. Gene and cell therapy for cystic fibrosis: from bench to bedside. Journal of Cystic Fibrosis, 2011; 10 (Suppl. 2): S114-S128 [doi: 10.1016/S1569-1993(11)60017-9].
10. Clancy JP, Rowe SM, Accurso FJ et al. Results of a phase IIa study of VX-809, an investigational CFTR corrector compound, in subjects with cystic fibrosis homozygous for the F508del-CFTR mutation. Thorax, 2012; 67: 12-18.
11. Green JM, Hewison J, Bekker HL, Bryant LD, Cuckle HS. Psychosocial aspects of genetic screening of pregnant women and newborns: a systematic review. Health Technology Assessment, 2004; 8.
12. American College of Obstetricians and Gynecologists. Update on carrier screening for cystic fibrosis. Committee Opinion No. 486. Obstet Gynecol, 2011; 117: 1028-1031.
13. Langfelder-Schwind E, Kloza E, Sugarman E et al. Cystic fibrosis prenatal screening in genetic counseling practice: recommendations of the national society of genetic counselors. Journal of Genetic Counseling, 2005; 14: 1-15.
14. Etchegary H, Potter B, Howley H, Cappelli M, Coyle D, Graham I, et al. The influence of experiential knowledge on prenatal screening and testing decisions. Genetic Testing, 2008; 12: 115-124.
15. Ahmed S, Atkin K, Hewison J, Green JM. The influence of faith and religion and the role of religious and community leaders in prenatal decisions for sickle cell disorders and thalassaemia major. Prenatal Diagnosis, 2006; 26: 801-809.
16. France EF, Locock L, Hunt K, Ziebland S, Field K, Wyke S. Imagined futures: how experiential knowledge of disability affects parents' decision making about fetal abnormality. Health Expectations, 2011; 15: 139-156.
17. Wilson J, Ferguson G, Thorn J. Genetic testing likelihood: the impact of abortion views and quality of life information on women's decisions. Journal of Genetic Counseling, 2011; 20: 143-156.
18. Gee L, Abbott J, Conway SP, Etherington C, Webb AK. Quality of life in cystic fibrosis: the impact of gender, general health perceptions and disease severity. Journal of Cystic Fibrosis, 2003; 2: 206-213.
19. Loeben GL, Marteau TM, Wilfond BS. Mixed messages: presentation of information in cystic fibrosis-screening pamphlets. American Journal of Human Genetics, 1998; 63: 1181-1189.
20. Bryant LD, Murray J, Green JM, Hewison J, Sehmi I, Ellis A. Descriptive information about Down syndrome: a content analysis of serum screening leaflets. Prenatal Diagnosis, 2001; 21: 1057-1063.
21. Petersen A. The best experts: the narratives of those who have a genetic condition. Social Science & Medicine, 2006; 63: 32-42.
22. Ahmed S, Bryant LD, Hewison J. 'Balance' is in the eye of the beholder: providing information to support informed choices in antenatal screening via AnSWeR. Health Expectations, 2007; 10: 309-320.
23. Madeo AC, Biesecker BB, Brasington C, Erby LH, Peters KF. The relationship between the genetic counseling profession and the disability community: a commentary. American Journal of Medical Genetics Part A, 2011; 155: 1777-1785.
24. Solberg B. Prenatal screening for Down syndrome: why we shouldn't? In: Kristiansen K, Vehmas S, Shakespeare T (eds) Arguing about Disability: Philosophical Perspectives. Abingdon, Oxon: Routledge, 2009: 185-202.
25. Parens E, Asch A. The disability rights critique of prenatal genetic testing: reflections and recommendations. Mental Retardation and Dev Disabilities Res Reviews, 2003; 9: 40-47.
26. Kerr A. Understanding genetic disease in a socio-historical context: a case study of cystic fibrosis. Sociology of Health & Illness, 2005; 27: 873-896.
27. Shakespeare T. Choices and rights: eugenics, genetics and disability equality. Disability and Society, 1998; 13: 665-681.
28. Lewis C, Mehta P, Kent A, Skirton H, Coviello D. An assessment of written patient information provided at the genetic clinic and relating to genetic testing in seven European countries. European Journal of Human Genetics, 2007; 15: 1012-1022.
29. Winterbottom A, Bekker HL, Conner M, Mooney A. Does narrative information bias individual's decision making? A systematic review. Social Science & Medicine, 2008; 67: 2079-2088.
30. Entwistle VA, France EF, Wyke S et al. How information about other people's personal experiences can help with healthcare decision-making: a qualitative study. Patient Education and Counseling, 2011; 85: e291-e298.
31. Herxheimer A, McPherson A, Miller R, Shepperd S, Yaphe J, Ziebland S. Database of patients' experiences (DIPEx): a multi-media approach to sharing experiences and information. The Lancet, 2000; 355: 1540-1543.
32. Stainton Rogers R. Q Methodology. In: Smith JA, Van Langenhove L (eds) Rethinking Methods in Psychology. London: Sage, 1995: 178-192.
33. Watts S, Stenner P. Doing Q methodology: theory, method and interpretation. Qualitative Research in Psychology, 2005; 2: 67-91.
34. Watts S, Stenner P. Q Methodology, Quantum Theory, and Psychology. Operant Subjectivity, 2003; 26 : 157-175.
35. Wright KF. Which Features of Cystic Fibrosis might Inform Pregnant Women's Prenatal Testing Decisions? Doctor of Clinical Psychology Thesis. Leeds, UK: University of Leeds, 2009.
36. Schmolck P, Atkinson J. PQMETHOD (Version 2.11) (2003). Available at: http://www.rz.unibw-muenchen.de/~p41bsmk/qmethod/: University of the Federal Armed Forces, Munich; accessed 20 June 2009.
37. Brown SR. Political Subjectivity: Applications of Q Methodology in Political Science. New Haven: Yale University Press, 1980.
38. Lowton K, Gabe J. Life on a slippery slope: perceptions of health in adults with cystic fibrosis. Sociology of Health & Illness, 2003; 25: 289-319.
39. Biesecker BB, Erby L. Adaptation to living with a genetic condition or risk: a mini-review. Clinical Genetics, 2008; 74: 401-407.
40. Sheets KB, Best RG, Brasington CK, Will MC. Balanced information about Down syndrome: what is essential? American Journal of Medical Genetics Part A, 2011; 155: 1246-1257.